{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:39:12Z","timestamp":1790779152628,"version":"4.1.0"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Recent studies have identified the critical role of microbiota in the pathophysiology of autoimmune liver diseases (AILDs), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC). Metagenomic studies reveal significant decrease of gut bacterial diversity in AILDs. Although profiles of metagenomic vary widely, <jats:italic>Veillonella<\/jats:italic> is commonly enriched in AIH, PBC, and PSC. Apart from gut microbiome, the oral and bile microbiome seem to be associated with these diseases as well. The functional analysis of metagenomics suggests that metabolic pathways changed in the gut microbiome of the patients. Microbial metabolites, including short-chain fatty acids (SCFAs) and microbial bile acid metabolites, have been shown to modulate innate immunity, adaptive immunity, and inflammation. Taken together, the evidence of host\u2013microbiome interactions and in-depth mechanistic studies needs further accumulation, which will offer more possibilities to clarify the mechanisms of AILDs and provide potential molecular targets for the prevention and treatment in the future.<\/jats:p>","DOI":"10.3389\/fphys.2021.715852","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T13:54:12Z","timestamp":1633874052000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes"],"prefix":"10.3389","volume":"12","author":[{"given":"Yanping","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangmao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jhep.2003.11.033","article-title":"Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?","volume":"40","author":"Abdulkarim","year":"2004","journal-title":"J. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198757","article-title":"Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.","volume":"13","author":"Abe","year":"2018","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial.","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000444471","article-title":"The pathogenesis of autoimmune liver disease.","volume":"34","author":"Arndtz","year":"2016","journal-title":"Dig. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-319-31248-4_4","article-title":"The oral microbiota.","volume":"902","author":"Arweiler","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.","volume":"23","author":"Bajer","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1478-3231.2008.01942.x","article-title":"Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis.","volume":"29","author":"Berg","year":"2009","journal-title":"Liver Int."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101497","article-title":"The microbiome and rheumatoid arthritis.","volume":"33","author":"Bergot","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01995","article-title":"Role of short chain fatty acids in controlling tregs and immunopathology during mucosal infection.","volume":"9","author":"Bhaskaran","year":"2018","journal-title":"Front. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102534","article-title":"The role of complement activation in autoimmune liver disease.","volume":"19","author":"Biewenga","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0168-8278(03)00501-4","article-title":"Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.","volume":"40","author":"Bogdanos","year":"2004","journal-title":"J. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jhep.2008.05.022","article-title":"Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis.","volume":"49","author":"Bogdanos","year":"2008","journal-title":"J Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.femsim.2004.11.002","article-title":"The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis.","volume":"44","author":"Boomkens","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/00365520903426915","article-title":"Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease.","volume":"45","author":"Casswall","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis.","volume":"58","author":"Chen","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.598152","article-title":"Gut microbiome of children and adolescents with primary sclerosing cholangitis in association with ulcerative colitis.","volume":"11","author":"Cortez","year":"2020","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood.","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00203-020-01931-x","article-title":"Human microbiome: an academic update on human body site specific surveillance and its possible role.","volume":"202","author":"Dekaboruah","year":"2020","journal-title":"Arch. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases.","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"B23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1023\/a:1013292210036","article-title":"Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis.","volume":"47","author":"Dohmen","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.3748\/wjg.v10.i21.3179","article-title":"Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis.","volume":"10","author":"Durazzo","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.620254","article-title":"The oral microbiome in pediatric IBD: a source of pathobionts or biomarkers?","volume":"8","author":"Elmaghrawy","year":"2020","journal-title":"Front Pediatr."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8071011","article-title":"Autoimmune hepatitis: shifts in gut microbiota and metabolic pathways among egyptian patients.","volume":"8","author":"Elsherbiny","year":"2020","journal-title":"Microorganisms"},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/apt.13008","article-title":"Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases.","volume":"41","author":"Felice","year":"2015","journal-title":"Aliment Pharmacol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"E2329","DOI":"10.1073\/pnas.1319284111","article-title":"Relating the metatranscriptome and metagenome of the human gut.","volume":"111","author":"Franzosa","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease.","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/hepr.13509","article-title":"Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis.","volume":"50","author":"Furukawa","year":"2020","journal-title":"Hepatol. Res."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00117","article-title":"New therapeutic targets in autoimmune cholangiopathies.","volume":"7","author":"Gerussi","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation.","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1053\/jhep.2001.22653","article-title":"Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation?","volume":"33","author":"Harada","year":"2001","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/labinvest.2010.40","article-title":"Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation.","volume":"90","author":"Haruta","year":"2010","journal-title":"Lab. Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1756283X12459294","article-title":"Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation.","volume":"6","author":"Hemarajata","year":"2013","journal-title":"Therap. Adv. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jhep.2016.09.002","article-title":"Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.","volume":"66","author":"Henriksen","year":"2017","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0168-8278(00)80153-1","article-title":"Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis.","volume":"33","author":"Hiramatsu","year":"2000","journal-title":"J. Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines.","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellimm.2018.03.003","article-title":"High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier.","volume":"328","author":"Hu","year":"2018","journal-title":"Cell. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.autrev.2005.01.005","article-title":"T cell immunity in autoimmune hepatitis.","volume":"4","author":"Ichiki","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/s1542-3565(04)00678-0","article-title":"From bases to basis: linking genetics to causation in primary biliary cirrhosis.","volume":"3","author":"Invernizzi","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s1568-9972(02)00122-2","article-title":"T cell immunity and primary biliary cirrhosis.","volume":"2","author":"Ishibashi","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1111\/j.1572-0241.2004.41121.x","article-title":"Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis.","volume":"99","author":"Kaplan","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12026-017-8906-2","article-title":"The microbiome and systemic lupus erythematosus.","volume":"65","author":"Katz-Agranov","year":"2017","journal-title":"Immunol. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/imm.12930","article-title":"Immune regulation by microbiome metabolites.","volume":"154","author":"Kim","year":"2018","journal-title":"Immunology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.4049\/jimmunol.173.4.2315","article-title":"Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain.","volume":"173","author":"Koarada","year":"2004","journal-title":"J. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s10620-007-9803-7","article-title":"Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis.","volume":"52","author":"Krasinskas","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jsap.12626","article-title":"Bacterial translocation in critical illness.","volume":"58","author":"Krentz","year":"2017","journal-title":"J. Small Anim. Pract."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/liv.14153","article-title":"The gut microbial influence on cholestatic liver disease.","volume":"39","author":"Kummen","year":"2019","journal-title":"Liver Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1784.e","DOI":"10.1053\/j.gastro.2020.12.058","article-title":"Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis.","volume":"160","author":"Kummen","year":"2020","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnab038","article-title":"Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis.","volume":"368","author":"Lammert","year":"2021","journal-title":"FEMS Microbiol. Lett."},{"key":"B52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12072-020-10089-z","article-title":"Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.","volume":"15","author":"Lapidot","year":"2021","journal-title":"Hepatol. Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000450906","article-title":"Role of the intestinal microbiome in cholestatic liver disease.","volume":"35","author":"LaRusso","year":"2017","journal-title":"Dig. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/gutjnl-2018-317791","article-title":"Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.","volume":"69","author":"Lemoinne","year":"2020","journal-title":"Gut"},{"key":"B55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/10446670310001642429","article-title":"Is there a relation between Chlamydia infection and primary biliary cirrhosis?","volume":"10","author":"Leung","year":"2003","journal-title":"Clin. Dev. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mib.2016.10.003","article-title":"Microbiome, metabolites and host immunity.","volume":"35","author":"Levy","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","article-title":"Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.","volume":"16","author":"Li","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"B58","first-page":"5153","article-title":"Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.","volume":"8","author":"Lin","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.3748\/wjg.v11.i26.4108","article-title":"Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis.","volume":"11","author":"Liu","year":"2005","journal-title":"World J Gastroenterol."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101537","article-title":"Probiotics in autoimmune and inflammatory disorders.","volume":"10","author":"Liu","year":"2018","journal-title":"Nutrients"},{"key":"B61","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis.","volume":"69","author":"Liwinski","year":"2020","journal-title":"Gut"},{"key":"B62","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hep.31523","article-title":"The commensal microbe veillonella as a marker for response to an FGF19 analog in NASH.","volume":"73","author":"Loomba","year":"2021","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00342","article-title":"Fecal microbiomes distinguish patients with autoimmune hepatitis from healthy individuals.","volume":"10","author":"Lou","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.7518\/hxkq.2020.05.018","article-title":"[Research progress in the relationship between Veillonella and oral diseases].","volume":"38","author":"Luo","year":"2020","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis.","volume":"18","author":"Lv","year":"2016","journal-title":"Environ. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.","volume":"51","author":"Lv","year":"2020","journal-title":"Aliment Pharmacol. Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans.","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.chembiol.2014.07.007","article-title":"Exploring metabolic pathways and regulation through functional chemoproteomic and metabolomic platforms.","volume":"21","author":"Medina-Cleghorn","year":"2014","journal-title":"Chem. Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1872-034X.2012.01088.x","article-title":"Role of gut microbiota in liver diseases.","volume":"43","author":"Miyake","year":"2013","journal-title":"Hepatol. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1128\/JCM.38.3.1072-1076.2000","article-title":"Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis.","volume":"38","author":"Nilsson","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00925","article-title":"Bifidobacteria and their role as members of the human gut microbiota.","volume":"7","author":"O\u2019Callaghan","year":"2016","journal-title":"Front. Microbiol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182924","article-title":"Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.","volume":"12","author":"Pereira","year":"2017","journal-title":"PLoS One"},{"key":"B74","doi-asserted-by":"publisher","first-page":"s15","DOI":"10.5604\/01.3001.0010.5494","article-title":"The role of the gut microbiota in bile acid metabolism.","author":"Ramirez-Perez","year":"2017","journal-title":"Ann. Hepatol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00482","article-title":"Comparative metatranscriptomics of periodontitis supports a common polymicrobial shift in metabolic function and identifies novel putative disease-associated ncRNAs.","volume":"11","author":"Ram-Mohan","year":"2020","journal-title":"Front. Microbiol."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0743-1","article-title":"Comparative analysis of amplicon and metagenomic sequencing methods reveals key features in the evolution of animal metaorganisms.","volume":"7","author":"Rausch","year":"2019","journal-title":"Microbiome"},{"key":"B77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.apsb.2015.01.006","article-title":"The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics.","volume":"5","author":"Ridlon","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"B78","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1023\/a:1022501102877","article-title":"Identification of beta-subunit of bacterial RNA-polymerase\u2013a non-species-specific bacterial protein\u2013as target of antibodies in primary biliary cirrhosis.","volume":"48","author":"Roesler","year":"2003","journal-title":"Dig. Dis. Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.","volume":"66","author":"Ruhlemann","year":"2017","journal-title":"Gut"},{"key":"B80","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/apt.15375","article-title":"Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.","volume":"50","author":"Ruhlemann","year":"2019","journal-title":"Aliment Pharmacol. Ther."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11460-x","article-title":"Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome.","volume":"10","author":"Russell","year":"2019","journal-title":"Nat. Commun."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1177\/1756284818787400","article-title":"Cholestatic liver diseases: new targets, new therapies.","volume":"11","author":"Santiago","year":"2018","journal-title":"Therap. Adv. Gastroenterol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/hep.1840120523","article-title":"Hepatic injury induced by bile salts: correlation between biochemical and morphological events.","volume":"12","author":"Schmucker","year":"1990","journal-title":"Hepatology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/00365528209182038","article-title":"HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease.","volume":"17","author":"Schrumpf","year":"1982","journal-title":"Scand. J. Gastroenterol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jhep.2016.09.020","article-title":"The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation.","volume":"66","author":"Schrumpf","year":"2017","journal-title":"J. Hepatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1113\/jphysiol.2011.219691","article-title":"Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.","volume":"590","author":"Seki","year":"2012","journal-title":"J. Physiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium.","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cmi.2009.104","article-title":"Experimental evidence on the immunopathogenesis of primary biliary cirrhosis.","volume":"7","author":"Selmi","year":"2010","journal-title":"Cell Mol. Immunol."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00904","article-title":"Advances and challenges in metatranscriptomic analysis.","volume":"10","author":"Shakya","year":"2019","journal-title":"Front. Genet."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-017-0122-9","article-title":"Interaction between the gut microbiome and mucosal immune system.","volume":"4","author":"Shi","year":"2017","journal-title":"Mil Med Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.181.5.1835","article-title":"DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.","volume":"181","author":"Shimoda","year":"1995","journal-title":"J. Exp. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/s0168-8278(99)80346-8","article-title":"Are infectious agents involved in primary biliary cirrhosis? APCR approach.","volume":"31","author":"Tanaka","year":"1999","journal-title":"J. Hepatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"B96","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3762\/bjoc.14.33","article-title":"Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review.","volume":"14","author":"Tonin","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1152\/physrev.2001.81.3.1031","article-title":"Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides.","volume":"81","author":"Topping","year":"2001","journal-title":"Physiol. Rev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/2050640617708953","article-title":"The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.","volume":"6","author":"Torres","year":"2018","journal-title":"U. Eur. Gastroenterol. J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/lt.25882","article-title":"Variation in bile microbiome by the etiology of cholestatic liver disease.","volume":"26","author":"Tyc","year":"2020","journal-title":"Liver Transpl."},{"key":"B100","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2018.10.009","article-title":"Shared gut, but distinct oral microbiota composition in primary Sjogren\u2019s syndrome and systemic lupus erythematosus.","volume":"97","author":"van der Meulen","year":"2019","journal-title":"J. Autoimmun."},{"key":"B101","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/gene.2014.82","article-title":"HLA-DRB1\u221703:01 and HLA-DRB1\u221704:01 modify the presentation and outcome in autoimmune hepatitis type-1.","volume":"16","author":"van Gerven","year":"2015","journal-title":"Genes Immun."},{"key":"B102","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/CEG.S186097","article-title":"A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis.","volume":"12","author":"Vaughn","year":"2019","journal-title":"Clin. Exp. Gastroenterol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1046\/j.1365-2362.1997.1690724.x","article-title":"Antibodies to mycobacterial 65-kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrhosis.","volume":"27","author":"Vilagut","year":"1997","journal-title":"Eur. J. Clin. Invest."},{"key":"B104","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/s0168-8278(94)80117-7","article-title":"Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis.","volume":"21","author":"Vilagut","year":"1994","journal-title":"J. Hepatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/MEG.0b013e3282f5197e","article-title":"Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study.","volume":"20","author":"Vleggaar","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0437-0","article-title":"Species classifier choice is a key consideration when analysing low-complexity food microbiome data.","volume":"6","author":"Walsh","year":"2018","journal-title":"Microbiome"},{"key":"B107","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3748\/wjg.v21.i3.803","article-title":"Application of metagenomics in the human gut microbiome.","volume":"21","author":"Wang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3892\/etm.2016.3977","article-title":"Fungal infection involvement in primary biliary cirrhosis: a review of 2 cases.","volume":"13","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis.","volume":"69","author":"Wei","year":"2020","journal-title":"Gut."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis.","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.imlet.2017.08.005","article-title":"Sodium butyrate ameliorates S100\/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway.","volume":"190","author":"Wu","year":"2017","journal-title":"Immunol. Lett."},{"key":"B112","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1348-0421.1994.tb01813.x","article-title":"Detection and characterization of antibodies to bacterial heat-shock protein 60 in sera of patients with primary biliary cirrhosis.","volume":"38","author":"Yamaguchi","year":"1994","journal-title":"Microbiol. Immunol."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10050983","article-title":"Immunohistochemical detection of potential microbial antigens in granulomas in the diagnosis of sarcoidosis.","volume":"10","author":"Yamaguchi","year":"2021","journal-title":"J. Clin. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000452300","article-title":"Bile acids and the potential role in primary biliary cirrhosis.","volume":"94","author":"Yang","year":"2016","journal-title":"Digestion"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.569104","article-title":"Bifidobacterium animalis ssp. Lactis 420 mitigates autoimmune hepatitis through regulating intestinal barrier and liver immune cells.","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624360","article-title":"Leaky gut driven by dysbiosis augments activation and accumulation of liver macrophages via RIP3 signaling pathway in autoimmune hepatitis.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0767-6","article-title":"Advancing functional and translational microbiome research using meta-omics approaches.","volume":"7","author":"Zhang","year":"2019","journal-title":"Microbiome"},{"key":"B118","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease.","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.649060","article-title":"Streptococcus, the predominant bacterium to predict the severity of liver injury in alcoholic liver disease.","volume":"11","author":"Zhong","year":"2021","journal-title":"Front. Cell Infect. Microbiol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.715852\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T13:54:17Z","timestamp":1633874057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.715852\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":119,"alternative-id":["10.3389\/fphys.2021.715852"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.715852","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"article-number":"715852"}}